Back to results
US 2018/0022710 A1Published application
Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
AssigneeSignal Pharmaceuticals, LLC
InventorsHon-Wah MAN, Mohit Atul KOTHARE
Life of this patent
Estimating the term…
Abstract
Provided herein are isotopologues of Compound A, which are enriched with isotopes such as, for example, deuterium. Pharmaceutical compositions comprising the isotope-enriched compounds, and methods of using such compounds are also provided. Embodiments provided herein encompass isotopologues of Compound A and pharmaceutically acceptable salts, stereoisomers, tautomers, solid forms, polymorphs, hydrates, clathrates, and solvates thereof.
Claims9
A compound, wherein the compound is an isotopologue of a compound having the following structure:
- or a pharmaceutically acceptable salt, stereoisomer, polymorph or solvate thereof.
Dependencies are inferred from the claim text.